Home › Funds › ABG-WTT Global Life Science Capital Partners GP Ltd › RPID
ABG-WTT Global Life Science Capital Partners GP Ltd position in RPID
RAPID MICRO BIOSYSTEMS INC · Industrials
ABG-WTT Global Life Science Capital Partners GP Ltd reported holding 1,848,296 shares of RPID (RAPID MICRO BIOSYSTEMS INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 100.00% of its reported portfolio and ranking #1 among its reported holdings. ABG-WTT Global Life Science Capital Partners GP Ltd has disclosed RPID holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How ABG-WTT Global Life Science Capital Partners GP Ltd's RPID position evolved
ABG-WTT Global Life Science Capital Partners GP Ltd first disclosed a stake in RPID in Q3 2023 at 1,038,296 shares (US$1.1M). The position peaked in Q2 2025 at 1,848,296 shares, worth US$6.4M. Across 13 filings, ABG-WTT Global Life Science Capital Partners GP Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 1,848,296 shares valued at US$1.9M. Notable position changes include a 78% increase in Q1 2025 (shares rose 31% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.04M | $1.12M | New |
| Q4 2023 | 1.04M | $768.34K | Hold |
| Q1 2024 | 1.04M | $768.34K | Hold |
| Q2 2024 | 1.04M | $685.27K | Hold |
| Q3 2024 | 1.04M | $924.08K | Hold |
| Q4 2024 | 1.04M | $934.47K | Hold |
| Q1 2025 | 1.85M | $4.88M | Add |
| Q2 2025 | 1.85M | $6.38M | Hold |
| Q3 2025 | 1.85M | $6.17M | Hold |
| Q4 2025 | 1.85M | $5.36M | Hold |
| Q1 2026 | 1.85M | $4.20M | Hold |
| Q2 2026 | 1.85M | $3.20M | Hold |
| Q3 2026 | 1.85M | $1.90M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RPID and 13F data
RPID (RAPID MICRO BIOSYSTEMS INC) is a Industrials company. 29 other funds we track also report a position in RPID — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$8.7M), DUPONT CAPITAL MANAGEMENT CORP (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RPID
- Bain Capital Life Sciences Investors, LLC 8.43M sh · $8.69M · Q3 2026
- DUPONT CAPITAL MANAGEMENT CORP 3.37K sh · $3.47M · Q3 2026
More on ABG-WTT Global Life Science Capital Partners GP Ltd
FAQ
How long has ABG-WTT Global Life Science Capital Partners GP Ltd held RPID?
ABG-WTT Global Life Science Capital Partners GP Ltd has disclosed RPID holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ABG-WTT Global Life Science Capital Partners GP Ltd's current position in RPID?
As of Q3 2026, ABG-WTT Global Life Science Capital Partners GP Ltd holds 1.85M shares of RPID (RAPID MICRO BIOSYSTEMS INC), valued at $1.90M, representing 100.00% of its reported portfolio and ranking #1.
Has ABG-WTT Global Life Science Capital Partners GP Ltd been buying or selling RPID?
In the latest 13F filing (Q3 2026), ABG-WTT Global Life Science Capital Partners GP Ltd held unchanged its position in RPID. The position peaked in Q2 2025 at 1.85M shares.
Which other funds hold RPID?
Other major institutional holders of RPID include Bain Capital Life Sciences Investors, LLC, DUPONT CAPITAL MANAGEMENT CORP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.